Abberior installs new STED microscope at MBC BioLabs
March 27, 2023Medical Communications
Abberior has announced that it has placed a super-resolution STED microscope at MBC BioLabs, which is the leading San Francisco …
FDA releases draft of accelerated approval guidance for oncology therapeutics
March 27, 2023Medical Communications
The FDA has released a draft of new guidance for accelerated approval for oncology therapeutics, highlighting the need for stricter …
University of Leipzig and SiSaf partner over Bio-Courier targeted miRNA
March 27, 2023Medical Communications
SiSaf, an RNA delivery and therapeutics company, has announced a collaboration with the University of Leipzig to develop Bio-Courier targeted …
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023Business Services
NEW YORK and BERLIN, March 24, 2023 (GLOBE NEWSWIRE) — atai Life Sciences&
Announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology Demonstrates significant reduction of nasal S. aureus in preoperative cardiac surgery patients
March 24, 2023Business Services
Brighton, United Kingdom – 24 March 2023 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the …
NICE recommends PTC Therapeutics’ gene therapy for NHS use
March 24, 2023Medical Communications
NICE has recommended PTC Therapeutics’ gene therapy to the NHS for the treatment of ultra-rare disease aromatic L-amino acid decarboxylase …
Creative Medical Technology files FDA ODD application for Brittle Type 1 diabetes
March 24, 2023Medical Communications
US-based biotech company Creative Medical Technology has announced that it has filed for the FDA’s Orphan Drug Designation (ODD) for …
European Commission delays release of major changes to pharma legislation
March 24, 2023Medical Communications
The European Commission (EC) has again delayed the release of its new proposal for changes to Europe’s pharma legislation. The …
NeuroRPM announces FDA clearance for AI monitoring app for Parkinson’s disease on Apple Watch
March 24, 2023Medical Communications
NeuroRPM has announced that it has received clearance from the FDA for its NeuroRPM device which uses AI and existing …
NICE publishes guidance recommending Bayer’s Kerendia® (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes
March 23, 2023Business Services
Reading, 23rd March 2023 – Today, the National Institute for Health and Care Excellence (NICE) has published a new guidance …
SYMBICORT (budesonide/formoterol) TURBOHALER 200/6 APPROVED AS FIRST AND ONLY COMBINATION RELIEVER FOR MILD ASTHMA IN THE UK
March 23, 2023Business Services
London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …
BIAL appoints Max Bricchi as Chief Commercial Officer
March 23, 2023Business Services
BIAL has announced the appointment of Max Bricchi as Chief Commercial Officer (CCO) and Executive Board member. With responsibility for …
Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting
March 23, 2023Business Services
Tokyo, Japan and Cambridge, UK, 23 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m
March 23, 2023Sales and Marketing
Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …
Biogen shares FDA decisions on ALS drug
March 23, 2023Research and Development
US-based Biogen has announced two decisions the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee made surrounding its ALS …
Incyte has announced FDA approval of Zynyz
March 23, 2023Medical Communications
Incyte has today announced that the FDA gas approved Zynyz (retifanlimab-dlwr) for the treatment of adult patients with metastatic or …
India cancels manufacturing licence for Marion Biotech after cough syrup deaths
March 23, 2023Medical Communications
Uttar Pradesh, a state in India, has cancelled the manufacturing licence of Marion Biotech after two cough syrups made at …
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
March 22, 2023Business Services
VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have …
Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data
March 22, 2023Business Services
Boston, March 22, 2023 — YonaLink, a clinical trial software provider, today announced its EHR-to-EDC data integration platform has been …
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
March 22, 2023Business Services
HERCULES, Calif. — March 15, 2023 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
